Metabolic Immunosuppression Mediated by Proliferative CD168+TAMs in Colon Cancer
Zhihao Wei, Yan Dong, Ruiyang Zi, Taorui Liu, Yahan Fan, Rui Zhang, Yongning Shang, Haoran Jiang, Xiang Zhao, Jianjun Li
This study identifies CD168+ TAMs as hyperproliferative, immunosuppressive cells in colon cancer driven by metabolic rewiring and CX3CR1 signaling.
bioRxiv · Sep 2, 2025 · PreprintCancer Biology